Torsten Danfors

A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using ¹¹C-PE2I PET

Falk, Linus; Brunius, Carl; Bojkovic, Tea Crnic; Appel, Lieuwe et al.

Part of NeuroImage, 2026

• DOI for A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using ¹¹C-PE2I PET
• Download full text (pdf) of A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using ¹¹C-PE2I PET

Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PET.

Kosek, Sonja; Kilsved, Ellen; Danfors, Torsten; Cunningham, Janet L et al.

Part of Clinical Nuclear Medicine, p. 208-213, 2025

• DOI for Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PET.

Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4

Schain, Martin; Johansson, Edvin; Laitinen, Iina; Frödén Löwenmark, Anna et al.

Part of Diabetologia, p. 1315-1328, 2025

• DOI for Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4
• Download full text (pdf) of Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4

Evaluation of [¹¹C]UCB-A positron emission tomography in human brains

Xiong, Mengfei; Lubberink, Mark; Appel, Lieuwe; Fang, Xiaotian Tsong et al.

Part of EJNMMI Research, 2024

• DOI for Evaluation of [¹¹C]UCB-A positron emission tomography in human brains
• Download full text (pdf) of Evaluation of [¹¹C]UCB-A positron emission tomography in human brains

An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease

Syk, Mikaela; Tornvind, Emma; Gallwitz, Maike; Fällmar, David et al.

Part of Translational Psychiatry, 2024

• DOI for An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease
• Download full text (pdf) of An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease

A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using ¹¹C-PE2I PET

Falk, Linus; Brunius, Carl; Bojkovic, Tea Crnic; Appel, Lieuwe et al.

Part of NeuroImage, 2026

• DOI for A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using ¹¹C-PE2I PET
• Download full text (pdf) of A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using ¹¹C-PE2I PET

Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PET.

Kosek, Sonja; Kilsved, Ellen; Danfors, Torsten; Cunningham, Janet L et al.

Part of Clinical Nuclear Medicine, p. 208-213, 2025

• DOI for Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PET.

Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4

Schain, Martin; Johansson, Edvin; Laitinen, Iina; Frödén Löwenmark, Anna et al.

Part of Diabetologia, p. 1315-1328, 2025

• DOI for Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4
• Download full text (pdf) of Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4

Evaluation of [¹¹C]UCB-A positron emission tomography in human brains

Xiong, Mengfei; Lubberink, Mark; Appel, Lieuwe; Fang, Xiaotian Tsong et al.

Part of EJNMMI Research, 2024

• DOI for Evaluation of [¹¹C]UCB-A positron emission tomography in human brains
• Download full text (pdf) of Evaluation of [¹¹C]UCB-A positron emission tomography in human brains

An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease

Syk, Mikaela; Tornvind, Emma; Gallwitz, Maike; Fällmar, David et al.

Part of Translational Psychiatry, 2024

• DOI for An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease
• Download full text (pdf) of An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease

Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [¹¹C]PE2I, [¹⁸F]FE-PE2I and [¹¹C]raclopride PET in healthy individuals

Jonasson, My; Frick, Andreas; Fazio, Patrik; Hjorth, Olof et al.

Part of Journal of Cerebral Blood Flow and Metabolism, p. 1206-1215, 2023

• DOI for Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [¹¹C]PE2I, [¹⁸F]FE-PE2I and [¹¹C]raclopride PET in healthy individuals

The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid beta fibril formation

de la Vega, Maria Pagnon; Giedraitis, Vilmantas; Michno, Wojciech; Kilander, Lena et al.

Part of Science Translational Medicine, 2021

• DOI for The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid beta fibril formation

Evaluation of Arterial Spin Labeling MRI: Comparison with ¹⁵O-Water PET on an Integrated PET/MR Scanner

Fahlström, Markus; Appel, Lieuwe; Kumlien, Eva; Danfors, Torsten et al.

Part of Diagnostics (Basel), 2021

• DOI for Evaluation of Arterial Spin Labeling MRI: Comparison with ¹⁵O-Water PET on an Integrated PET/MR Scanner
• Download full text (pdf) of Evaluation of Arterial Spin Labeling MRI: Comparison with ¹⁵O-Water PET on an Integrated PET/MR Scanner

Phenotypic variability in chorea-acanthocytosis associated with novel VPS13A mutations

Niemelä, Valter; Salih, Ammar; Solea, Daniela; Lindvall, Bjoern et al.

Part of Neurology Genetics, 2020

• DOI for Phenotypic variability in chorea-acanthocytosis associated with novel VPS13A mutations
• Download full text (pdf) of Phenotypic variability in chorea-acanthocytosis associated with novel VPS13A mutations

Image reconstruction methods affect software-aided assessment of pathologies of [¹⁸F]flutemetamol and [¹⁸F]FDG brain-PET examinations in patients with neurodegenerative diseases

Lindström, Elin; Oddstig, Jenny; Danfors, Torsten; Jögi, Jonas et al.

Part of NeuroImage, 2020

• DOI for Image reconstruction methods affect software-aided assessment of pathologies of [¹⁸F]flutemetamol and [¹⁸F]FDG brain-PET examinations in patients with neurodegenerative diseases
• Download full text (pdf) of Image reconstruction methods affect software-aided assessment of pathologies of [¹⁸F]flutemetamol and [¹⁸F]FDG brain-PET examinations in patients with neurodegenerative diseases

Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity

Roodakker, Kenney Roy; Alhuseinalkhudhur, Ali; Al-Jaff, Mohammed; Georganaki, Maria et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 569-579, 2019

• DOI for Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity

Evaluation of penalized likelihood estimation reconstruction on a digital time-of-flight PET/CT scanner for 18F-FDG whole-body examinations

Lindström, Elin; Sundin, Anders; Trampal, Carlos; Lindsjö, Lars et al.

Part of Journal of Nuclear Medicine, p. 1152-1158, 2018

• DOI for Evaluation of penalized likelihood estimation reconstruction on a digital time-of-flight PET/CT scanner for 18F-FDG whole-body examinations

Blood Flow Dependence of Early [C-11]PE2I and [F-18]FE-PE2I PET SUVR Measurements Used In the Differential Diagnosis of Parkinsonian Disorders

Jonasson, My; Langaas, G.; Appel, Lieuwe; Danfors, Torsten et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Flutemetamol and FDG Brain-PET Image Reconstruction Methods Affect Software-Aided Diagnosis in Patients with Neurodegenerative Diseases

Lindström, Elin; Oddstig, J.; Danfors, Torsten; Lindsjö, L. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Differential diagnosis of patients with parkinsonian syndrome using multilinear regression to disease-specific C-11-PE2I-PET templates and classification tree learning

Lubberink, Mark; Widström, Charles; Jonasson, My; Appel, Lieuwe et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Z-score maps from low-dose ¹⁸F-FDG PET of the brain in neurodegenerative dementia.

Fällmar, David; Lilja, Johan; Danfors, Torsten; Kilander, Lena et al.

Part of American Journal of Nuclear Medicine and Molecular Imaging, p. 239-246, 2018

Development of a clinically feasible [11C]PE2I PET method for differential diagnosis of parkinsonism using reduced scan duration and automated reference region extraction.

Jonasson, My; Appel, Lieuwe; Danfors, Torsten; Nyholm, Dag et al.

Part of American Journal of Nuclear Medicine and Molecular Imaging, p. 263-274, 2017

• Download full text (pdf) of Development of a clinically feasible [11C]PE2I PET method for differential diagnosis of parkinsonism using reduced scan duration and automated reference region extraction.

Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET.

Fällmar, David; Haller, Sven; Lilja, Johan; Danfors, Torsten et al.

Part of European Radiology, p. 4237-4246, 2017

• DOI for Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET.
• Download full text (pdf) of Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET.

Tracer kinetic analysis of the SV2A ligand ¹¹C-UCBA as a PET marker for synaptic density in humans

Lubberink, Mark; Appel, Lieuwe; Gaging, Johannes; Lindskog, Karolina et al.

Part of Journal of Nuclear Medicine, 2017

Optimisation of penalized likelihood estimation reconstruction (Q.Clear) on a digital time-of-flight PET-CT scanner for four different PET tracers

Lindström, Elin; Lindsjö, Lars; Ilan, Ezgi; Sundin, Anders et al.

Part of Journal of Nuclear Medicine, 2017

Quantitative assessment of synaptic density using the SV2A ligand C-11-UCBA in humans

Lubberink, Mark; Appel, Lieuwe; Lindskog, K.; Danfors, Torsten et al.

Part of Journal of Cerebral Blood Flow and Metabolism, p. 74-74, 2017

Validation of true low-dose ¹⁸F-FDG PET of the brain

Fällmar, David; Lilja, Johan; Kilander, Lena; Danfors, Torsten et al.

Part of American Journal of Nuclear Medicine and Molecular Imaging, p. 269-276, 2016

Validation of Zero-Echo Time PET-MR against stand-alone PET using dynamic dopamine transporter imaging

Sousa, Joao M.; Appel, Lieuwe; Papadimitriou, S.; Nyholm, Dag et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Visual Assessment of Brain Perfusion MRI Scans in Dementia: a Pilot Study

Fällmar, David; Lilja, Johan; Velickaite, Vilma; Danfors, Torsten et al.

Part of Journal of Neuroimaging, p. 324-330, 2016

• DOI for Visual Assessment of Brain Perfusion MRI Scans in Dementia: a Pilot Study

Long-term evaluation of the effect of hypofractionated high-energy proton treatment of benign meningiomas by means of (11)C-L-methionine positron emission tomography

Ryttlefors, Mats; Danfors, Torsten; Latini, Francesco; Montelius, Anders et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1432-1443, 2016

• DOI for Long-term evaluation of the effect of hypofractionated high-energy proton treatment of benign meningiomas by means of (11)C-L-methionine positron emission tomography

Validation of true low-dose 18F-FDG PET of the brain

Fällmar, David; Lilja, Johan; Kilander, Lena; Danfors, Torsten et al.

Part of American Journal of Nuclear Medicine and Molecular Imaging, p. 269-276, 2016

• Download full text (pdf) of Validation of true low-dose 18F-FDG PET of the brain

The role of methionine positron emission tomography in the evaluation of central nervous system tumors in children

Danfors, Torsten; Velickaite, Vilma; Canto Moreira, Nuno

Part of Journal of Cerebral Blood Flow and Metabolism, p. 394-395, 2016

Use of C-11-PE2I PET in Differential Diagnosis of Parkinsonian Disorders

Appel, Lieuwe; Jonasson, My; Danfors, Torsten; Nyholm, Dag et al.

Part of Journal of Nuclear Medicine, p. 234-242, 2015

• DOI for Use of C-11-PE2I PET in Differential Diagnosis of Parkinsonian Disorders

Seizure outcomes in relation to the extent of resection of the perifocal fluorodeoxyglucose and flumazenil PET abnormalities in anteromedial temporal lobectomy

Stanisic, Milo; Coello, Christopher; Ivanovic, Jugoslav; Egge, Arild et al.

Part of Acta Neurochirurgica, p. 1905-1916, 2015

• DOI for Seizure outcomes in relation to the extent of resection of the perifocal fluorodeoxyglucose and flumazenil PET abnormalities in anteromedial temporal lobectomy
• Download full text (pdf) of Seizure outcomes in relation to the extent of resection of the perifocal fluorodeoxyglucose and flumazenil PET abnormalities in anteromedial temporal lobectomy

Differential diagnosis of therapy-related changes and recurrent intracranial tumours using perfusion MRI and methionine PET

Romanos Zapata, Romina; Danfors, Torsten; Wikström, Johan; Raininko, Raili

Part of Insights into Imaging, 2014

• DOI for Differential diagnosis of therapy-related changes and recurrent intracranial tumours using perfusion MRI and methionine PET

Validation of parametric methods for [(11)C]PE2I positron emission tomography

Jonasson, My; Appel, Lieuwe; Engman, Jonas; Frick, Andreas et al.

Part of NeuroImage, p. 172-178, 2013

• DOI for Validation of parametric methods for [(11)C]PE2I positron emission tomography

Parametric methods for [¹¹C]PE2I positron emission tomography

Jonasson, My; Appel, Lieuwe; Engman, Jonas; Frick, Andreas et al.

Part of Journal of Cerebral Blood Flow and Metabolism, 2012

• DOI for Parametric methods for [¹¹C]PE2I positron emission tomography

PET response and tumor stabilization under erlotinib and bevacizumab treatment of an intracranial lesion non-invasively diagnosed as likely chordoma

Asklund, T; Danfors, Torsten; Henriksson, R

Part of Clinical Neuropathology, p. 242-246, 2011

• DOI for PET response and tumor stabilization under erlotinib and bevacizumab treatment of an intracranial lesion non-invasively diagnosed as likely chordoma

Increased neurokinin-1 receptor availability in temporal lobe epilepsy: A positron emission tomography study using [(11)C]GR205171

Danfors, Torsten; Åhs, Fredrik; Appel, Lieuwe; Linnman, Clas et al.

Part of Epilepsy Research, p. 183-189, 2011

• DOI for Increased neurokinin-1 receptor availability in temporal lobe epilepsy: A positron emission tomography study using [(11)C]GR205171

Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure

Sikk, K; Taba, P; Haldre, S; Bergquist, Jonas et al.

Part of Acta Neurologica Scandinavica, p. 237-243, 2010

• DOI for Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure

Epileptic seizures and survival in early disease of grade 2 gliomas

Danfors, Torsten; Ribom, Dan; Berntsson, Shala G.; Smits, Anja

Part of European Journal of Neurology, p. 823-831, 2009

• DOI for Epileptic seizures and survival in early disease of grade 2 gliomas

Tetrahydrobiopterin in the treatment of children with autistic disorder. A double-blind placebo-controlled crossover study

Danfors, Torsten; von Knorring, Anne-Liis; Hartvig, Per; Långström, Bengt et al.

Part of Journal of Clinical Psychopharmacology, p. 485-489, 2005

The Uppsala APP deletion causes early onset autosomal dominant Alzheimer’s disease by altering APP processing and increasing amyloid-β fibril formation

Pagnon de la Vega, María; Giedraitis, Vilmantas; Michno, Wojciech; Kilander, Lena et al.

Part of Science Translational Medicine

Akutneurologi

Danfors, Torsten; Fagius, Ja

Part of Neurologi, p. 568, Liber AB, Stockholm, 2006

¹¹C Molecular Imaging in Focal Epilepsy

Danfors, Torsten

2012

• Download full text (pdf) of ¹¹C Molecular Imaging in Focal Epilepsy

Relative Cerbral Blood Flow Measurement using dynamic Flumazenil-PET may Replace Fluorodeoxyglucose-PET in Epilepsy Surgical Investigations

Danfors, Torsten; Sörensen, Jens; Lubberink, Mark; Kumlien, Eva

2012

¹¹C-autoradiographic studies of dynamic changes in glial cells and benzodiazepine receptor binding in a model of posttraumatic epilepsy

Danfors, Torsten; Samuelsson, Carolina; Estrada, Sergio; Mats, Bergström et al.

Biological markers for CNS damage in a patient cohort with suspected autoimmune psychiatric disease

Syk, Mikaela; Malmström, Emma; Gallwitz, Maike; Fällmar, David et al.

Cerebral blood flow in multiple sclerosis: an ¹⁵O-water PET study

Tolf, Andreas; Hedman, Karolina; Appel, Lieuwe; Larsson, Elna-Marie et al.